Objective: Patients with auditory neuropathy spectrum disorder (ANSD) exhibit altered neural synchrony in response to auditory stimuli. Cochlear implantation (CI) is thought to improve neural synchrony in response to auditory stimuli and improve speech perception relative to conventional hearing amplification (HA).
Objective: Patients with auditory neuropathy spectrum disorder (ANSD) exhibit altered neural synchrony in response to auditory stimuli. Cochlear implantation (CI) is thought to improve neural synchrony in response to auditory stimuli and improve speech perception relative to conventional hearing amplification (HA).
Method:
Retrospective review was performed of 40 patients with ANSD treated at Vanderbilt University in 1999-2011. Twenty-two patients underwent CI, 11 received HA only, and 7 were observed. Pretreatment performance was assessed through parent questionnaire (IT-MAIS) and speech/language evaluation. Posttreatment outcomes were assessed using IT-MAIS and closed/open-set speech perception scores.
Results: Average follow-up for all patients was 36 months (range 0-90). Two of 7 observed patients exhibited neuromaturation over time. Median available pretreatment IT-MAIS scores were 13 and 34 for CI and HA groups, respectively (difference NS, rank sum test, P = .06). All CI patients had a prior HA trial with failure of auditory skills development. Posttreatment, 15/20 CI patients and 5/11 HA patients with available data achieved closed/open-set speech perception scores ≥60%. No differences between groups were found in post-treatment IT-MAIS scores (rank sum test, P = .69) or the percentage of patients achieving the above levels of closed/ open-set speech perception (Fisher's exact test, P = .13).
Conclusion:
In our ANSD population, patients undergoing CI achieved at least comparable and possibly improved overall speech perception outcomes relative to HAs despite a greater initial level of auditory impairment as assessed by parent questionnaire. These findings further validate use of CIs in ANSD patients with failure of auditory skills development.
Otology/Neurotology
Combination Therapy for the Treatment of idiopathic SSNHl Alex Battaglia, MD, PhD (presenter); Annette Lualhati; Raoul Burchette; Roberto A. Cueva, MD Objective: To determine whether combination therapy (highdose prednisone taper [HDPT]+intratympanic dexamethasone [IT-Dex]) improves pure tone average scores (PTA) and speech discrimination scores (SDS) relative to HDPT alone or intratympanic steroid (IT-S) alone in patients with idiopathic sudden sensorineural hearing loss (ISSNHL).
Method: From June 2008 to January 2012, 84 (15 dropouts) patients diagnosed with ISSNHL were administered IT-De (10 mg/cc) once-a-week for 3 weeks + HDPT (60 mg/day for 7 days with 7-day taper). Final audiogram results are compared to previously published results of combination therapy, HPDT alone, and IT-S alone.
Results: Treatment began on average 6.6 days after onset of ISSNHL. The average pretreatment 3-tone PTA was 83.2, and the average pretreatment SDS was 16%. The overall PTA improved significantly by an average of -38. The overall SDS improved significantly by an average of 49%. The average overall posttreatment SDS was 65%. 60/69 (87%) patients started with an SDS score less than or equal to 50%, and 38 (63%) of these ended above 50%. 24/42 (57%) of the profound patients recovered with an SDS above 50%. According to published reports, HDPT and IT-S alone improve SDS by only 39%.
Conclusion: ISSNHL patients treated with IT-De+ HDPT experienced statistically significant PTA and SDS improvements, comparable to previously published combination therapy results. The audiologic data indicate that combination therapy improves hearing recovery relative to HDPT or IT-S alone, possibly by improving hair cell and spiral ganglion survival. Method: Controlled animal experiment. Thirty-six guinea pigs underwent middle ear surgery with mucosal trauma performed on both ears. One ear was packed with either PUF or AGS. Contralateral ears were used as nonpacked paired controls. Auditory brainstem response (ABR) thresholds were measured preoperatively and repeated at 1, 2, and 6 weeks postoperatively. Histological analysis was done by a pathologist blinded to the type of packing using hematoxylin and eosin staining to measure inflammatory reaction and trichome staining to measure fibrosis in each group.
Results: ABR recordings demonstrates that threshold level changes from baseline were minor in the PUF and the control groups. Threshold levels were higher in the AGS group compared with both control groups and the PUF group for the 1 KHz and 0.5 KHz frequencies. Macoscopic analysis showed no tympanic membrane perforation and packing material was absorbed in all groups at 6 weeks postoperatiely. The histological analysis showed normal mucosal healing in the PUF and control groups. There was more packing retention, inflammation, and osteoneogenesis in the AGS group than the PUF or either control group.
